My mother was recently (April 2017) diagnosed with CML- chronic phase and she was initially put on 400 mg of generic Imatinib. The result was a drastic loss in the wbc and platelet level. She was then moved to 200 mg Imatinib with not much change. The medication has now been changed to 50 mg Sprycel however, her wbc and platelet count still remains low. There was a lot of dose interruption with both Imatinib and Sprycel in order to maintain the blood count within the normal range.
Has anyone else encountered such a situation?